Home » Nine Indian Drug Firms May Have to Pay $419 Million
Nine Indian Drug Firms May Have to Pay $419 Million
Nine Indian pharma firms including Ranbaxy and Dr. Reddy’s may have to pay fines of approximately $419 million for selling the asthma drug Doxofylline without first getting the drug’s price approved.
Business Standard
Business Standard
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May